Progyny, Inc. Operating Income
Progyny, Inc. (PGNY) reported Operating Income of $40.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-07
- Progyny, Inc. operating income (loss) for the quarter ending 2026-06-30 was $40.00M, a 64.23% increase year-over-year.
- Progyny, Inc. operating income (loss) for the quarter ending 2026-03-31 was $35.38M, a 46.38% increase year-over-year.
- Progyny, Inc. operating income (loss) for the quarter ending 2025-12-31 was $15.22M, a 3.58% decline year-over-year.
- Progyny, Inc. operating income (loss) for the quarter ending 2025-09-30 was $21.53M, a 72.80% increase year-over-year.
- Progyny, Inc. operating income (loss) for fiscal 2025 was $85.28M, a 26.42% increase from fiscal 2024.
- Progyny, Inc. operating income (loss) for fiscal 2024 was $67.45M, a 8.48% increase from fiscal 2023.
- Progyny, Inc. operating income (loss) for fiscal 2023 was $62.18M, a 166.42% increase from fiscal 2022.
- Progyny, Inc. operating income (loss) for fiscal 2022 was $23.34M, a 27.83% decline from fiscal 2021.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $40.00M 10-Q · filed 2026-08-07 | $75.38M 10-Q · filed 2026-08-07 | $90.60M derived: sum of 3 quarters · filed 2026-08-07 | $112.13M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2026-03-31 | $35.38M 10-Q · filed 2026-05-08 | $50.60M derived: sum of 2 quarters · filed 2026-05-08 | $72.13M derived: sum of 3 quarters · filed 2026-05-08 | $96.49M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-12-31 | $15.22M 10-K · filed 2026-02-27 | $36.75M derived: sum of 2 quarters · filed 2026-02-27 | $61.11M derived: sum of 3 quarters · filed 2026-08-07 | $85.28M 10-K · filed 2026-02-27 | |||
| 2025-09-30 | $21.53M 10-K · filed 2026-02-27 | $45.88M derived: sum of 2 quarters · filed 2026-08-07 | $70.06M 10-Q · filed 2025-11-07 | $85.84M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-06-30 | $24.36M 10-Q · filed 2026-08-07 | $48.53M 10-Q · filed 2026-08-07 | $64.31M derived: sum of 3 quarters · filed 2026-08-07 | $76.77M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-03-31 | $24.17M 10-Q · filed 2026-05-08 | $39.96M derived: sum of 2 quarters · filed 2026-05-08 | $52.41M derived: sum of 3 quarters · filed 2026-05-08 | $73.10M derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | $15.79M 10-K · filed 2026-02-27 | $28.25M derived: sum of 2 quarters · filed 2026-02-27 | $48.93M derived: sum of 3 quarters · filed 2026-02-27 | $67.45M 10-K · filed 2026-02-27 | |||
| 2024-09-30 | $12.46M 10-K · filed 2026-02-27 | $33.15M derived: sum of 2 quarters · filed 2026-02-27 | $51.67M 10-Q · filed 2025-11-07 | $65.47M derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2024-06-30 | $20.69M 10-K · filed 2026-02-27 | $39.21M 10-Q · filed 2025-08-08 | $53.01M derived: sum of 3 quarters · filed 2026-02-27 | $71.20M derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2024-03-31 | $18.52M 10-K · filed 2026-02-27 | $32.32M derived: sum of 2 quarters · filed 2026-02-27 | $50.51M derived: sum of 3 quarters · filed 2026-02-27 | $65.70M derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2023-12-31 | $13.80M 10-K · filed 2025-03-03 | $31.99M derived: sum of 2 quarters · filed 2025-03-03 | $47.17M derived: sum of 3 quarters · filed 2025-03-03 | $62.18M 10-K · filed 2026-02-27 | |||
| 2023-09-30 | $18.19M 10-K · filed 2025-03-03 | $33.37M derived: sum of 2 quarters · filed 2025-03-03 | $48.38M 10-Q · filed 2024-11-12 | $51.69M derived: sum of 4 quarters · filed 2025-03-03 | |||
| 2023-06-30 | $15.18M 10-K · filed 2025-03-03 | $30.20M 10-Q · filed 2024-08-07 | $33.50M derived: sum of 3 quarters · filed 2025-03-03 | $44.76M derived: sum of 4 quarters · filed 2025-03-03 | |||
| 2023-03-31 | $15.01M 10-K · filed 2025-03-03 | $18.32M derived: sum of 2 quarters · filed 2025-03-03 | $29.57M derived: sum of 3 quarters · filed 2025-03-03 | $38.41M derived: sum of 4 quarters · filed 2025-03-03 | |||
| 2022-12-31 | $3.31M 10-K · filed 2024-02-29 | $14.56M derived: sum of 2 quarters · filed 2024-02-29 | $23.40M derived: sum of 3 quarters · filed 2024-02-29 | $23.34M 10-K · filed 2025-03-03 | |||
| 2022-09-30 | $11.26M 10-K · filed 2024-02-29 | $20.09M derived: sum of 2 quarters · filed 2024-02-29 | $20.04M 10-Q · filed 2023-11-08 | $19.85M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-06-30 | $8.84M 10-K · filed 2024-02-29 | $8.78M 10-Q · filed 2023-08-04 | $8.59M derived: sum of 3 quarters · filed 2024-02-29 | $17.66M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-03-31 | -$58.00K 10-K · filed 2024-02-29 | -$246.00K derived: sum of 2 quarters · filed 2024-02-29 | $8.82M derived: sum of 3 quarters · filed 2024-02-29 | $20.48M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2021-12-31 | -$188.00K 10-K · filed 2023-03-01 | $8.88M derived: sum of 2 quarters · filed 2023-03-01 | $20.53M derived: sum of 3 quarters · filed 2023-03-01 | $32.34M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $9.06M 10-K · filed 2023-03-01 | $20.72M derived: sum of 2 quarters · filed 2023-03-01 | $32.53M 10-Q · filed 2022-11-04 | $33.69M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-06-30 | $11.66M 10-K · filed 2023-03-01 | $23.46M 10-Q · filed 2022-08-05 | $24.62M derived: sum of 3 quarters · filed 2023-03-01 | $29.45M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-03-31 | $11.81M 10-K · filed 2023-03-01 | $12.97M derived: sum of 2 quarters · filed 2023-03-01 | $17.80M derived: sum of 3 quarters · filed 2023-03-01 | $16.72M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2020-12-31 | $1.16M 10-K · filed 2022-03-01 | $5.99M derived: sum of 2 quarters · filed 2022-03-01 | $4.92M derived: sum of 3 quarters · filed 2022-03-01 | $8.35M 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $4.83M 10-K · filed 2022-03-01 | $5.36M 10-Q · filed 2020-11-06 | $3.76M derived: sum of 2 quarters · filed 2022-03-01 | $7.19M 10-Q · filed 2021-11-08 | $7.40M 10-Q · filed 2020-11-06 | $8.33M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | -$1.07M 10-K · filed 2022-03-01 | -$1.82M 10-Q · filed 2020-08-07 | $2.36M 10-Q · filed 2021-08-06 | $2.04M 10-Q · filed 2020-08-07 | $3.50M derived: sum of 3 quarters · filed 2022-03-01 | $6.57M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | $3.43M 10-K · filed 2022-03-01 | $3.86M 10-Q · filed 2020-05-14 | $4.58M derived: sum of 2 quarters · filed 2022-03-01 | $7.64M derived: sum of 3 quarters · filed 2022-03-01 | $10.00M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | $1.14M 10-K · filed 2021-03-01 | $4.21M derived: sum of 2 quarters · filed 2021-03-01 | $6.57M derived: sum of 3 quarters · filed 2021-03-01 | $9.68M 10-K · filed 2022-03-01 | |||
| 2019-09-30 | $3.07M 10-K · filed 2021-03-01 | $5.42M derived: sum of 2 quarters · filed 2021-03-01 | $8.53M 10-Q · filed 2020-11-06 | $7.83M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-06-30 | $2.35M 10-K · filed 2021-03-01 | $5.46M 10-Q · filed 2020-08-07 | $4.76M derived: sum of 3 quarters · filed 2021-03-01 | $4.17M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-03-31 | $3.11M 10-K · filed 2021-03-01 | $2.41M derived: sum of 2 quarters · filed 2021-03-01 | $1.82M derived: sum of 3 quarters · filed 2021-03-01 | $1.50M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2018-12-31 | -$703.00K 10-K · filed 2020-03-10 | -$1.29M derived: sum of 2 quarters · filed 2020-03-10 | -$1.61M derived: sum of 3 quarters · filed 2020-03-10 | -$3.45M 10-K · filed 2021-03-01 | |||
| 2018-09-30 | -$587.00K 10-K · filed 2020-03-10 | -$904.00K derived: sum of 2 quarters · filed 2020-03-10 | -$2.75M 10-Q · filed 2019-12-06 | ||||
| 2018-06-30 | -$317.00K 10-K · filed 2020-03-10 | -$2.16M derived: sum of 2 quarters · filed 2020-03-10 | |||||
| 2018-03-31 | -$1.84M 10-K · filed 2020-03-10 | ||||||
| 2017-12-31 | -$11.01M 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |